Storbank blåstempler Kåre Schultz' plan for Teva: Aktien er »for billig til at ignorere«
UBS: Tvivl om størrelse på mulig erstatning i Teva-sager - kan løbe op i større milliardbeløb
Stock Picks to Buy, 13 Contrarian Names and Rationale for Each: UBS
Why Teva Pharmaceutical Industries, Intrepid Potash, and Ensco Slumped Today | Nasdaq
UBS — EMMA KOLB
UBS reiterates Teva's Buy rating but cuts price target - Globes
UBS nedjusterer Teva Pharmaceuticals efter Kåre Schultz indgår forlig i USA
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
UBS barberer en tredjedel af kursmål for Teva
Teva completes $3.2b acquisition of Auspex - Globes
Rebounding Teva is 'too cheap to ignore,' upbeat analysts say | Fierce Pharma
Most Active Foreign Bonds 21.05.2021 – Teva Pharma, Gazprom, New York Life, Deutsche Bahn, Russian Railways, UBS London Branch – Financial Markets Blog
UBS Sees China Private Banking Revenue Pool Hitting $163 Billion - BNN Bloomberg
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
Teva's collapse – Israel's biotech recovery - The Jerusalem Post
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
UBS raises Teva price target - Globes
Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target
Teva: 35% of senior management are women - Globes
Exclusive: UBS in talks with China Life for China asset management JV - sources - Headquarters Finance
A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides
